Pharma Reviews: Budget 2020: Nirmala Sitharaman may restore tax benefits on R&D for pharma companies

Budget 2020: The government is mulling restoring tax benefits on research and development (R&D) cost incurred by local pharma companies in the ...
Read more: Budget 2020: Nirmala Sitharaman may restore tax benefits on R&D for pharma companies